Cryo-Cell International Inc
AMEX:CCEL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cryo-Cell International Inc
AMEX:CCEL
|
US |
|
KIYO Learning Co Ltd
TSE:7353
|
JP |
|
C
|
Cresud SACIF y A
BCBA:CRES
|
AR |
|
R
|
Robotis Co Ltd
KOSDAQ:108490
|
KR |
|
A
|
Amata VN PCL
SET:AMATAV
|
TH |
|
Svolder AB
STO:SVOL A
|
SE |
|
Madison Technologies Inc
OTC:MDEX
|
CA |
|
Omni Bridgeway Ltd
ASX:OBL
|
AU |
|
Horizon Oil Ltd
ASX:HZN
|
AU |
|
AngioDynamics Inc
NASDAQ:ANGO
|
US |
|
Genex Power Ltd
ASX:GNX
|
AU |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
|
S
|
Svenska Aerogel Holding AB (publ)
STO:AERO
|
SE |
|
A
|
Ambient Water Corp
OTC:DRFS
|
US |
|
Super House Ltd
NSE:SUPERHOUSE
|
IN |
Cryo-Cell International Inc
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.
Cryo-Cell International, Inc. is cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. The company is headquartered in Oldsmar, Florida and currently employs 83 full-time employees. The firm operates through three segments: The cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use; the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells, and the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives and other related healthcare professionals. The Company, in combination with its global affiliates, stores approximately 500,000 cord blood and cord tissue specimens around the world for the benefit of newborn babies and possibly other members of their families. Its processing and storage of specimens is handled from its facility in Oldsmar, Florida.
